Eichler, Martin ORCID: 0000-0001-9654-2207, Andreou, Dimosthenis, Golcher, Henriette, Hentschel, Leopold, Richter, Stephan, Hohenberger, Peter, Kasper, Bernd ORCID: 0000-0001-8425-8356, Pink, Daniel ORCID: 0000-0001-7243-7373, Jakob, Jens, Ashmawy, Hany, Hettmer, Simone, Tuchscherer, Armin, Grube, Matthias, Heidt, Vitali, Jentsch, Christina, Pablik, Jessica, Wardelmann, Eva, Kreitner, Karl-Friedrich, Kneser, Ulrich, Tonus, Carolin, Wimberger, Pauline, Schoffer, Olaf ORCID: 0000-0001-6922-7148, Reichardt, Peter, Wartenberg, Markus, Eberlein-Gonska, Maria, Bornhauser, Martin, Schmitt, Jochen ORCID: 0000-0003-0264-0960 and Schuler, Markus K. (2021). Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study. Oncol. Res. Treat., 44 (6). S. 301 - 310. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Abstract

Background: Data on institutional structures of sarcoma care in Germany are scarce. The utilization of an interdisciplinary tumor board (IDTB) is an essential part of modern cancer care. We investigated to which extent and when IDTB are used in sarcoma care. We hypothesized that IDTB before treatment initiation were used more often at certified cancer centers and at high-volume centers and that IDTB utilization increased over time. Methods: From 2017 to 2020 we conducted a prospective cohort study, undertaking major efforts to include the whole spectrum of sarcoma treatment facilities. To analyze potential predictors of IDTB utilization, we calculated multivariable logistic regressions. Results: Patients and survivors (n = 1,309) from 39 study centers (22 tertiary referral hospitals, 9 other hospitals, and 8 office-based practices) participated; 88.3% of the patients were discussed at some stage of their disease in an IDTB (56.1% before treatment, 78% after therapy, and 85.9% in metastatic disease). Hypotheses were confirmed regarding the utilization of IDTB in certified cancer centers (vs. all others: OR = 5.39; 95% CI 3.28-8.85) and the time of diagnosis (2018/2019 vs. until 2013: OR = 4.95; 95% CI 2.67-9.21). Conclusion:Our study adds to the evidence regarding the institutional structures of sarcoma care in Germany. Utilization of a tumor board before therapy seems to be in an implementation process that is making progress but is far from complete. Certification is a possible tool to accelerate this development.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Eichler, MartinUNSPECIFIEDorcid.org/0000-0001-9654-2207UNSPECIFIED
Andreou, DimosthenisUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Golcher, HenrietteUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hentschel, LeopoldUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Richter, StephanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hohenberger, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kasper, BerndUNSPECIFIEDorcid.org/0000-0001-8425-8356UNSPECIFIED
Pink, DanielUNSPECIFIEDorcid.org/0000-0001-7243-7373UNSPECIFIED
Jakob, JensUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ashmawy, HanyUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hettmer, SimoneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tuchscherer, ArminUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grube, MatthiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heidt, VitaliUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jentsch, ChristinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pablik, JessicaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wardelmann, EvaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kreitner, Karl-FriedrichUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kneser, UlrichUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tonus, CarolinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wimberger, PaulineUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schoffer, OlafUNSPECIFIEDorcid.org/0000-0001-6922-7148UNSPECIFIED
Reichardt, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wartenberg, MarkusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Eberlein-Gonska, MariaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bornhauser, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmitt, JochenUNSPECIFIEDorcid.org/0000-0003-0264-0960UNSPECIFIED
Schuler, Markus K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-604534
DOI: 10.1159/000516262
Journal or Publication Title: Oncol. Res. Treat.
Volume: 44
Number: 6
Page Range: S. 301 - 310
Date: 2021
Publisher: KARGER
Place of Publication: BASEL
ISSN: 2296-5262
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/60453

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item